DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Sykes DA, Bradley ME, Riddy DM. et al.
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
Mol Pharmacol 2016;
89: 593-605
DOI: 10.1124/mol.115.101832.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.